Evidence map›Paper›PMID 34081287›Full record

ArticleAnnals of nuclear medicine2021

[

Rui Luo, Lei Wang, Fei Ye, Yan-Rong Wang, Wei Fang, Ming-Rong Zhang, Feng Wang

Open access · hybridAbstract read
In one paragraph

Article in Annals of nuclear medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. A first-in-man study of [Annals of nuclear medicine · 2024
    Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Rui LuoDepartment of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, 68 Changle Road, Nanjing, 210006, China.
Lei WangDepartment of Nuclear Medicine, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
Fei YeDeparment of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Yan-Rong WangDepartment of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, 68 Changle Road, Nanjing, 210006, China.
Wei FangDepartment of Nuclear Medicine, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
Ming-Rong ZhangDepartment of Advanced Nuclear Medicine Sciences, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan.
Feng WangDepartment of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, 68 Changle Road, Nanjing, 210006, China. fengwangcn@hotmail.com.
Nanjing Medical University · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNNational Institutes for Quantum and Radiological Science and Technology · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study aimed to evaluate the biodistribution and kinetics of [

methodsThe radiochemical purity and stability of [

resultsRadioactivity levels (%ID/g) in the myocardium in normal mice, determined by [

conclusion[

Indexed as

Myocardial IschemiaPositron Emission Tomography Computed TomographyAnimalsEarly DiagnosisMaleMiceMitochondriaPyrazolesRatsRats, Sprague-DawleyReceptors, GABATissue DistributionPyrazolesReceptors, GABA18FFEDACMitochondrial dysfunctionMyocardial injuryPETTSPO

Identifiers

PMID34081287
PMCPMC8285353
OpenAlexW3165383997

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.